Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
0 competitors in Pancreatic Ductal Adenocarcinoma (PDAC)
View Full LandscapeTarget Indication
Pancreatic Ductal Adenocarcinoma (PDAC)
Clinical Trial
NCT07644559Last updated: 6/13/2026
No patent data available. Pre-approval drugs may not have Orange Book listings.
Low Grade Serous Ovarian Cancer
Low Grade Ovarian Serous Adenocarcinoma
KRAS Activating Mutation
Low Grade Serous Ovarian Cancer
Non Small Cell Lung Cancer